ASCO 2022 Conference Coverage
Video Player is loading.
10 seconds
Playback speed
Lecture Summary - ASCO 2022 on Investigating a Switch Maintenance Concept With 5-FU + Bev After FOLFIRI + Cetuximab Induction Treatment vs. Continued Treatment With FOLFIRI + Cetuximab: Report of a Secondary Endpoint of the Phase-III FIRE-4 Study
By
ASCO 2022 Conference Coverage
FEATURING
Sebastian Stintzing
By
ASCO 2022 Conference Coverage
FEATURING
Sebastian Stintzing
Comments 0
Login to view comments.
Click here to Login
